Risk of serotonin syndrome associated with serotonin blocking drugs used to treat nausea and vomiting

 Health Canada has completed a safety review of the serotonin blocking drugs dolasetron (ANZEMET), granisetron (KYTRIL and generics), ondansetron (ZOFRAN and generics) and palonosetron (ALOXI), which are used for treating nausea and vomiting. This review identified a potential risk of serotonin syndrome.

For more information please go to  http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39519a-eng.php

Health care Disclaimer: 
The contents of this site (OpenDoor) are for informational purposes only and are meant to be discussed with your physician or other qualified health care professional before being acted on.

Browse More Articles

Tweet

Written by Unknown

OpenDoor aims to provide Health Awareness. l OpenDoor is a platform used to Learn and Coach.